| Literature DB >> 26754411 |
Abstract
BACKGROUND: Dogs [Canis lupus familiaris] were the first animal species to be domesticated and continue to occupy an important place in human societies. Recent studies have begun to reveal when and where dog domestication occurred. While much progress has been made in identifying the genetic basis of phenotypic differences between dog breeds we still know relatively little about the genetic changes underlying the phenotypes that differentiate all dogs from their wild progenitors, wolves [Canis lupus]. In particular, dogs generally show reduced aggression and fear towards humans compared to wolves. Therefore, selection for tameness was likely a necessary prerequisite for dog domestication. With the increasing availability of whole-genome sequence data it is possible to try and directly identify the genetic variants contributing to the phenotypic differences between dogs and wolves.Entities:
Mesh:
Year: 2016 PMID: 26754411 PMCID: PMC4710014 DOI: 10.1186/s12862-015-0579-7
Source DB: PubMed Journal: BMC Evol Biol ISSN: 1471-2148 Impact factor: 3.260
Fig. 1Genome-wide scan for selective sweeps. Z-transformed mean Fst calculated in 500kb genomic windows across the autosomes and X chromosome between dogs and wolves. Each point represents a 500kb window. A dashed horizontal line represents our threshold for identifying putatively selected regions (>5 Z(Fst)). 18 windows exceed this threshold and are considered as putative selective sweeps
Genes in 500kb windows with Z transformed mean Fst scores five standard deviations above the mean
| Chromosome | Window [bp] | Mean Fst | Genes in window |
|---|---|---|---|
| 1 | 2500001–3000000 | 0.427497 | SNORA70, GALR1 MBP, ZNF236 |
| 1 | 3000001–3500000 | 0.429086 | U6, ZNF516 |
| 6 | 47000001–47500000 | 0.429446 | RNPC3 |
| 16 | 7000001–7500000 | 0.411249 | PRSS58, MGAM, TAS2R38, CLEC5A, PRSS37, U6, TAS2R5, TAS2R3, SSBP1, WEE2 |
| 18 | 500001–1000000 | 0.388113 | |
| X | 66000001–66500000 | 0.445258 | ZNF711, POF1B, 7S |
| X | 77000001–77500000 | 0.53831 | TCEAL1, MORF4L2, GLRA4, TMEM31, PLP1, RAB9B, SLC25A53, 7SK, |
| X | 77500001–78000000 | 0.388753 | FAM199X, ESX1 |
| X | 78000001–78500000 | 0.473412 | |
| X | 79500001–80000000 | 0.46818 | U6, TBG, MUM1L1 |
| X | 80000001–80500000 | 0.458387 | U6, CXorf57, RNF128, RNF128, TBC1D8B, CLDN2, RIPPLY1, MORC4 |
| X | 80500001–81000000 | 0.407971 | RBM41, NUP62CL, PIH1D3 |
| X | 105500001–106000000 | 0.404133 | MOSPD1, ZNF75D, U6, ZNF449, DDX26B |
| X | 106000001–106500000 | 0.386268 | SLC9A6 |
| X | 108000001–108500000 | 0.493717 | |
| X | 108500001–109000000 | 0.524088 | FGF13, cfa-mir-504 |
| X | 109000001–109500000 | 0.467526 | |
| X | 109500001–110000000 | 0.511206 | F9, MCF2, U4, ATP11C, cfa-mir-505, CXorf66 |
Putatively functional variants fixed for alternative alleles between dogs and wolves
| Gene ID | Gene name | Position [chr:position] | Nucleotide change [Dog/Wolf] | Predicted effect |
|---|---|---|---|---|
|
| Fibroblast growth factor 13 | X:108729524 | C/G | 5‘-UTR |
|
| Four and a half LIM domains 1 | X:106604107 | A/G | 3‘- UTR |
|
| coagulation factor IX | X:109533147 | C/A | 3‘- UTR |
|
| MAP7 domain containing | X:106609169 | C/T | 3‘- UTR |
|
| Myelin basic protein | 1:2951693 | G/C | 3‘- UTR |
|
| MCF.2 cell line derived transforming sequence | X:109544224 | G/C | 3‘- UTR |
|
| Relt tumor necrosis factor receptor | 21:24836981 | G/A | 3‘- UTR |
|
| RNA-binding region containing 3 | 6:47026666 | T/G | Missense [T/P] |
|
| RNA-binding region containing 3 | 6:47035497 | A/C | Splice region, intronic |
|
| Solute carrier family 9, subfamily A | X:106463600 | T/C | 3‘- UTR |
| Novel protein coding | ENSCAFG00000018988 | X:108560105 | T/C | Missense [I/T] |
| Novel protein coding | ENSCAFG00000018988 | X:108560351 | A/G | Missense [Q/R] |
| Novel protein coding | ENSCAFG00000018988 | X:108560422 | G/A | Missense [E/K] |
| Novel protein coding | ENSCAFG00000018988 | X:108560629 | A/G | Missense [M/V] |
| Novel protein coding | ENSCAFG00000023289 | X:77456592 | G/A | Missense [E/K] |
Panther pathways gene enrichment analysis of genes containing variants with an Fst score > = 0.75
| PANTHER Pathways | Canis familiaris - REFLIST [19662] | Genes with putatively functional variants [848] | Expected number | Fold enrichment |
|
|---|---|---|---|---|---|
| Unclassified | 17318 | 712 | 746.91 | - | 0.00E00 |
| Adrenaline and noradrenaline biosynthesis | 26 | 9 | 1.12 | + | 4.19E-08 |
| Axon guidance mediated by netrin | 38 | 7 | 1.64 | + | 2.31E-01 |
| Dopamine receptor mediated signaling pathway | 51 | 8 | 2.20 | + | 2.97E-01 |
| Nicotine pharmacodynamics pathway | 31 | 6 | 1.34 | + | 3.87E-01 |
| Alpha adrenergic receptor signaling pathway | 22 | 5 | .95 | + | 4.45E-01 |
| Gonadotropin releasing hormone receptor pathway | 225 | 19 | 9.70 | + | 7.74E-01 |
Putatively functional variants with an Fst score > = 0.75 in genes in the ‘adrenaline and noradrenaline biosynthesis’ pathway
| Gene ID | Gene name | Position [chr:position] | Nucleotide change [Dog/Wolf] | Predicted effect |
|---|---|---|---|---|
|
| Dopa decarboxylase [Aromatic-L-Amino-Acid decarboxylase] | 18:1806717 | C/T | Missense [R/Q] |
|
| Amine oxidase [flavin-containing] A | X:37747023 | T/C | 3‘-UTR |
|
| Amine oxidase [flavin-containing] B | X:37766049 | C/T | 3‘-UTR |
|
| Sodium-dependent dopamine transporter member 3 | 34:11239621 | C/T | Splice region, intronic |
|
| Sodium-dependent neutral amino acid transporter member 17 | 6:41776709 | C/A | 3‘-UTR |
|
| Sodium-dependent neutral amino acid transporter member 19 | 34:11329939 | G/A | 3‘-UTR |
|
| Synaptosomal-associated protein 29 | 26:30614788 | C/T | Missense [S/N] |
|
| Synaptosomal-associated protein 29 | 26:30607948 | G/A | 3‘-UTR |
|
| Synaptosomal-associated protein 29 | 26:30607975 | T/C | 3‘-UTR |
|
| Synaptosomal-associated protein 29 | 26:30608088 | T/C | 3‘-UTR |
|
| Synaptosomal-associated protein 29 | 26:30608209 | G/A | 3‘-UTR |
|
| Synaptosomal-associated protein 29 | 26:30608212 | T/C | 3‘-UTR |
|
| Synaptosomal-associated protein 29 | 26:30608354 | A/G | 3‘-UTR |
|
| Synaptosomal-associated protein 29 | 26:30608375 | C/T | 3‘-UTR |
|
| Synaptosomal-associated protein 29 | 26:30608864 | A/G | 3‘-UTR |
|
| Synaptosomal-associated protein 29 | 26:30608989 | C/T | 3‘-UTR |
|
| Synaptosomal-associated protein 29 | 26:37750228 | T/A | 3‘-UTR |
|
| Synaptosomal-associated protein 29 | 26:38554416 | G/A | 3‘-UTR |
|
| Syntaxin-7 | 1:25559797 | T/C | 3‘-UTR |
|
| Tyrosine 3-monooxygenase | 18:46331581 | G/A | Splice region, intronic |
Fig. 2Percentage of functional sites in discrete Fst bins. Polymorphic sites and substitutions were ordered into bins based on their Fst score. For each bin sites were categorized according to their putative function. The number of sites in each functional category are plotted as a percentage of the total sites in that bin. Values at top refer to total number of sites in each bin. Synonymous sites, which are assumed to be selectively neutral, decline as a percentage of total sites as the Fst score of the bin increases. In contrast, we observe an increase in the percentage of several categories functional sites in the top bins [0.95–1, 1]. This may be the result of positive selection raising these variants to high frequency and fixation
Fig. 3Distribution of mean Fst in 50kb windows centered around putatively functional sites. Polymorphic sites with Fst > =0.75 between dogs and wolves were classified according to their putative function. For each putatively functional site the mean Fst was calculated in a 50kb window centered on the site. A violin plot shows the distribution of mean Fst values for each category of functional site (5‘-UTR, 3‘-UTR, non-synonymous, splice site, stop gained, synonymous). Synonymous mutations were included as a category to show the expectation in the absence of positive selection